Mogamulizumab (Synonyms: KW-0761) |
| Catalog No.GC69484 |
Mogamulizumab (KW-0761) is a recombinant anti-CCR4 monoclonal antibody (MAb) that removes fucosylation and can eliminate tumor cells through antibody-dependent cell-mediated cytotoxicity (ADCC). Mogamulizumab is being studied for its potential use in cancer, adult T-cell leukemia/lymphoma (ATLL), and cutaneous T-cell lymphoma (CTCL).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1159266-37-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Mogamulizumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Mogamulizumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *